Further, a recent report using a cultured hepatoma cell line showed that IL-6 counteracted the growth inhibitory influence of TGF-β1, primarily through the activation of multiple anti-apoptotic signaling pathways [29]. Here, IL6 is linked to hepatocellular carcinoma.